Layoffs at Arbutus Biopharma
- Layoff events
- 3
- verified and sourced
- Roles reported
- Not stated
- no source gives a number
- Announced between
- Nov 2023 to Mar 2025
- Reported by
- Arbutus Biopharma / U.S. SEC and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Arbutus Biopharma: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Arbutus Biopharma |
Restructuring
Arbutus Biopharma announced a 57% workforce reduction as it narrowed operations to a core team supporting its hepatitis B clinical program. |
Not known | 57% | Company-wide |
1 source for Arbutus Biopharma |
|
| Arbutus Biopharma |
Restructuring
Arbutus Biopharma announced a 40% workforce reduction as it cut discovery work and a mid-stage trial. |
Not known | 40% | Company-wide |
1 source for Arbutus Biopharma |
|
| Arbutus Biopharma |
Restructuring
Arbutus Biopharma announced a 24% workforce reduction as it redirected resources from research programs toward clinical development. |
Not known | 24% | United States |
1 source for Arbutus Biopharma |
Where this comes from
Every cut listed for Arbutus Biopharma was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Arbutus Biopharma? Tell us on our Discord and we will check it.